{"id":"https://openalex.org/W2589340597","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e15010","title":"Early outcome results of a phase I/II study for an IL-2/T-cell receptor fusion protein in combination with gemcitabine and cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer.","display_name":"Early outcome results of a phase I/II study for an IL-2/T-cell receptor fusion protein in combination with gemcitabine and cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer.","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2589340597","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e15010","mag":"2589340597"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.e15010","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e15010","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e15010","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086173392","display_name":"Julio J. Hajdenberg","orcid":"https://orcid.org/0000-0001-6346-1638","observed_orcids":["https://orcid.org/0000-0001-6346-1638"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio Hajdenberg","raw_affiliation_strings":["M. D. Anderson Cancer Center Orlando, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center Orlando, Orlando, FL","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109243891","display_name":"Danny A. Landau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danny Landau","raw_affiliation_strings":["M. D. Anderson Cancer Center Orlando, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center Orlando, Orlando, FL","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045207535","display_name":"Daniel A. Vaena","orcid":"https://orcid.org/0000-0001-5389-9193","observed_orcids":["https://orcid.org/0000-0001-5389-9193"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Vaena","raw_affiliation_strings":["University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005003137","display_name":"Mayer Fishman","orcid":"https://orcid.org/0000-0003-0185-1432","observed_orcids":["https://orcid.org/0000-0003-0185-1432"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mayer N. Fishman","raw_affiliation_strings":["H. Lee Moffitt Cancer Canter & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Canter & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024594616","display_name":"Charles Joel Rosser","orcid":"https://orcid.org/0000-0002-6052-4223","observed_orcids":["https://orcid.org/0000-0002-6052-4223"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Joel Rosser","raw_affiliation_strings":["M. D. Anderson Cancer Center Orlando, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center Orlando, Orlando, FL","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089777560","display_name":"Mohammed M. Milhem","orcid":"https://orcid.org/0000-0003-4663-6824","observed_orcids":["https://orcid.org/0000-0003-4663-6824"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]},{"id":"https://openalex.org/I2802216851","display_name":"University of Iowa Hospitals and Clinics","ror":"https://ror.org/04g2swc55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I126307644","https://openalex.org/I2802216851","https://openalex.org/I4210142782"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed M. Milhem","raw_affiliation_strings":["University of Iowa Hospital and Clinics, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa Hospital and Clinics, Iowa City, IA","institution_ids":["https://openalex.org/I126307644","https://openalex.org/I2802216851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047177507","display_name":"Jeffrey S. Weber","orcid":"https://orcid.org/0000-0002-4962-2957","observed_orcids":["https://orcid.org/0000-0002-4962-2957"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Weber","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037001918","display_name":"Virginia Rizzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virginia Rizzo","raw_affiliation_strings":["M. D. Anderson Cancer Center Orlando, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center Orlando, Orlando, FL","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054502088","display_name":"Pamela S Zehr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela Zehr","raw_affiliation_strings":["University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038798150","display_name":"Irene Williams-Elson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene Williams-Elson","raw_affiliation_strings":["H. Lee Moffitt Cancer Canter & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Canter & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059906816","display_name":"Peter R. Rhode","orcid":"https://orcid.org/0000-0002-4067-4021","observed_orcids":["https://orcid.org/0000-0002-4067-4021"]},"institutions":[{"id":"https://openalex.org/I4210131977","display_name":"Altor BioScience (United States)","ror":"https://ror.org/03p81a485","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Rhode","raw_affiliation_strings":["Altor BioScience, Miramar, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altor BioScience, Miramar, FL","institution_ids":["https://openalex.org/I4210131977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066815307","display_name":"Tessa Schutt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131977","display_name":"Altor BioScience (United States)","ror":"https://ror.org/03p81a485","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tessa Schutt","raw_affiliation_strings":["Altor BioScience, Miramar, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altor BioScience, Miramar, FL","institution_ids":["https://openalex.org/I4210131977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070635105","display_name":"Liza Hernandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131977","display_name":"Altor BioScience (United States)","ror":"https://ror.org/03p81a485","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Hernandez","raw_affiliation_strings":["Altor BioScience, Miramar, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altor BioScience, Miramar, FL","institution_ids":["https://openalex.org/I4210131977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113990669","display_name":"Bee-Yau Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131977","display_name":"Altor BioScience (United States)","ror":"https://ror.org/03p81a485","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bee-Yau Huang","raw_affiliation_strings":["Altor BioScience, Miramar, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altor BioScience, Miramar, FL","institution_ids":["https://openalex.org/I4210131977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069160791","display_name":"Hing C. Wong","orcid":"https://orcid.org/0000-0002-6865-4313","observed_orcids":["https://orcid.org/0000-0002-6865-4313"]},"institutions":[{"id":"https://openalex.org/I4210131977","display_name":"Altor BioScience (United States)","ror":"https://ror.org/03p81a485","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hing C. Wong","raw_affiliation_strings":["Altor BioScience, Miramar, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altor BioScience, Miramar, FL","institution_ids":["https://openalex.org/I4210131977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"e15010","last_page":"e15010"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/locally-advanced-urothelial-cancer","display_name":"locally advanced urothelial cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.47200000286102295},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6790000200271606},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5640000104904175},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.5839999914169312},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.42399999499320984},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.38999998569488525},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.43799999356269836},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.5389999747276306},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/radical-cystectomy","display_name":"radical cystectomy","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.921161413192749},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7525766491889954},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6651595234870911},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5832297801971436},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5450366735458374},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5381138920783997},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5213286280632019},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45555007457733154},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4438513517379761},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4157117009162903},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37802714109420776}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.e15010","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e15010","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e15010","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7799999713897705,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2118940674","https://openalex.org/W2913827242","https://openalex.org/W1974473042","https://openalex.org/W2011851765","https://openalex.org/W1970498696","https://openalex.org/W2035930906","https://openalex.org/W1977727607","https://openalex.org/W2167571882","https://openalex.org/W2033082527","https://openalex.org/W2320262955"],"abstract_inverted_index":{"e15010":[0],"Background:":[1],"ALT-801":[2,31,108,141,174,239,286],"is":[3,272,282],"a":[4,14,117,154,257,289],"human":[5],"IL-2/single-chain":[6],"T-cell":[7],"receptor":[8],"fusion":[9],"protein":[10],"previously":[11,207],"tested":[12],"in":[13,17,124,149,284],"phase":[15,268],"1":[16,99],"patients":[18,125,183,189],"with":[19,69,80,126,153,159,201,236],"advanced":[20],"malignancy":[21],"(Fishman":[22],"2011":[23],"CCR":[24],"17:7765)":[25],"(CA097550).":[26],"In":[27],"various":[28],"murine":[29],"models,":[30],"demonstrated":[32],"potent":[33],"activity":[34],"against":[35],"syngeneic":[36],"and":[37,75,107,194,211,232,238],"xenograft":[38],"UC,":[39],"suggesting":[40],"sensitivity":[41],"of":[42,72,78,83,92,94,173],"this":[43],"disease":[44,163],"to":[45,56,146],"IL-2":[46],"based":[47],"immunotherapy":[48,292],"(Wong,":[49],"unpubl.":[50],"data.).":[51],"Although":[52],"UC":[53,127,182],"are":[54,67,144],"sensitive":[55],"platinum-based":[57],"chemotherapy,":[58],"combinations":[59],"such":[60],"as":[61],"gemcitabine":[62],"(G)":[63],"+":[64],"cisplatin":[65],"(C)":[66],"associated":[68],"CR":[70],"rates":[71],"around":[73],"15%,":[74],"limited":[76,81],"durability":[77],"responses":[79],"effects":[82],"retreatment.":[84],"Methods:":[85],"We":[86],"report":[87],"here":[88],"initial":[89],"efficacy":[90],"results":[91],"co-administration":[93],"G":[95],"(1000":[96],"mg/m2/dose,":[97,104],"d":[98,105,111],"&":[100],"8),":[101],"C":[102],"(70":[103],"1)":[106],"(escalating":[109],"doses,":[110],"3,":[112],"5,":[113],"8,":[114],"10)":[115],"on":[116],"21":[118],"day":[119],"schedule,":[120],"for":[121,134,293],"3":[122,165,244],"cycles,":[123],"that":[128,285],"was":[129],"locally":[130],"advanced,":[131],"or":[132],"metastatic,":[133],"whom":[135],"GC":[136,217,237],"chemotherapy":[137],"would":[138],"be":[139,288],"considered.":[140],"planned":[142,273],"doses":[143,172],"0.04":[145,202],"0.12":[147],"mg/kg/dose":[148],"5":[150],"dose":[151],"cohorts":[152],"3+3":[155],"escalation":[156],"design.":[157],"Subjects":[158],"at":[160,274],"least":[161],"stable":[162],"after":[164],"courses":[166],"may":[167,287],"receive":[168],"4":[169],"additional":[170],"weekly":[171],"alone.":[175],"Results:":[176],"To":[177],"date,":[178],"three":[179],"Stage":[180],"IV":[181],"(1F,":[184],"2M;":[185],"59-63":[186],"yrs;":[187],"2":[188],"had":[190,206,212,245,256],"predominantly":[191],"nodal":[192],"metastases":[193],"one":[195],"patient":[196,252],"liver":[197],"metastases)":[198],"completed":[199],"treatment":[200],"mg/kg":[203],"ALT-801+GC.":[204],"Two":[205],"undergone":[208],"radical":[209,254],"cystectomy":[210,255],"then":[213],"later":[214],"failed":[215],"following":[216],"treatment.":[218,266],"Grade":[219],"3/4":[220],"toxicities":[221],"observed":[222],"include":[223],"neutropenia":[224],"(2),":[225,227],"thrombocytopenia":[226],"leukopenia":[228],"(1),":[229,234],"lymphopenia":[230],"(1)":[231],"anemia":[233],"consistent":[235],"known":[240],"pharmacodynamic":[241],"effects.":[242],"All":[243],"radiological":[246],"CRs":[247],"by":[248],"week":[249],"13.":[250],"One":[251],"underwent":[253],"pCR.":[258],"The":[259,278],"next":[260],"(0.06":[261],"mg/kg/dose)":[262],"cohort":[263,271],"has":[264],"started":[265],"A":[267],"II":[269],"expansion":[270],"the":[275],"MTD.":[276],"Conclusions:":[277],"early":[279],"response":[280],"pattern":[281],"encouraging":[283],"novel,":[290],"active":[291],"UC.":[294],"NCT01326871":[295]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}